Novabiotics Limited
Records under this name other than the patents Novabiotics Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 6 of 6 · Back to Novabiotics Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,785,375 | Cyclic Antimicrobial Peptides for Treating Bacterial Infections Lapsed on the fee record Ended Jul 22, 2026 · High confidence | Lapsed on the fee record | Ended Jul 22, 2026 | High confidence |
| US 7,847,059 | Methods for treatment of a dermatophytic fungal infection Term ended Term ended Aug 18, 2025 · USPTO record | Term ended | Term ended Aug 18, 2025 | USPTO record |
| US 8,088,888 | Method of treatment of a fungal infection with poly arginine peptides Term ended Ended no later than Aug 18, 2025 · USPTO record | Term ended | Ended no later than Aug 18, 2025 | USPTO record |
| US 8,470,769 | Method of treatment of bacterial infection by administration of poly-lysine Term ended Term ended Mar 14, 2025 · USPTO record | Term ended | Term ended Mar 14, 2025 | USPTO record |
| US 8,350,003 | Method of treatment of non-dermatophytic fungal infections Lapsed on the fee record Ended Jan 8, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 8, 2021 | USPTO record |
| US 9,181,303 | Treatment of Bacterial Infections with Cyclic Antimicrobial Peptides Lapsed on the fee record Ended Nov 10, 2019 · High confidence | Lapsed on the fee record | Ended Nov 10, 2019 | High confidence |